AR052132A1 - Polimorfos de {5-[3-(4,6-difloruro-1h- benzoimidazol-2-il)-1h-indazol-5-il]-4- metil-piridin-3- ilmetil}-etil- amina - Google Patents
Polimorfos de {5-[3-(4,6-difloruro-1h- benzoimidazol-2-il)-1h-indazol-5-il]-4- metil-piridin-3- ilmetil}-etil- aminaInfo
- Publication number
- AR052132A1 AR052132A1 ARP050104791A ARP050104791A AR052132A1 AR 052132 A1 AR052132 A1 AR 052132A1 AR P050104791 A ARP050104791 A AR P050104791A AR P050104791 A ARP050104791 A AR P050104791A AR 052132 A1 AR052132 A1 AR 052132A1
- Authority
- AR
- Argentina
- Prior art keywords
- indazol
- pyridin
- ethyl
- methyl
- benzoimidazol
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Composiciones farmacéuticas que los contienen. Reivindicacion 1: Una forma cristalina de {5-[3-(4,6-difluoro-1H-benzoimidazol-2-il)-1H-indazol-5-il]-4-metil-piridin-3-ilmetil}-etil-amina, representada por la formula (1), en la que la forma cristalina es un polimorfo sustancialmente puro de la forma B. Reivindicacion 9: Una forma cristalina de {5-[3-(4,6-difluoro-1H-benzoimidazol-2-il)-1H-indazol-5-il]-4-metil-piridin-3-ilmetil}-etil-amina, representada por la formula (1), en la que la forma cristalina es un polimorfo sustancialmente puro de la forma C.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US62901004P | 2004-11-17 | 2004-11-17 | |
US67262305P | 2005-04-18 | 2005-04-18 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR052132A1 true AR052132A1 (es) | 2007-03-07 |
Family
ID=35583419
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP050104791A AR052132A1 (es) | 2004-11-17 | 2005-11-15 | Polimorfos de {5-[3-(4,6-difloruro-1h- benzoimidazol-2-il)-1h-indazol-5-il]-4- metil-piridin-3- ilmetil}-etil- amina |
Country Status (4)
Country | Link |
---|---|
US (1) | US20060167056A1 (es) |
AR (1) | AR052132A1 (es) |
TW (1) | TW200630360A (es) |
WO (1) | WO2006054143A1 (es) |
Families Citing this family (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20120121540A1 (en) * | 2007-08-10 | 2012-05-17 | Franz Ulrich Schmitz | Certain Nitrogen Containing Bicyclic Chemical Entities For Treating Viral Infections |
US8252812B2 (en) | 2009-08-10 | 2012-08-28 | Samumed, Llc | Indazole inhibitors of the WNT signal pathway and therapeutic uses thereof |
CA2770320A1 (en) * | 2009-08-10 | 2011-02-17 | Epitherix, Llc | Indazoles as wnt/b-catenin signaling pathway inhibitors and therapeutic uses thereof |
JP5822844B2 (ja) | 2009-12-21 | 2015-11-24 | サミュメッド リミテッド ライアビリティ カンパニー | 1H−ピラゾロ[3,4−b]ピリジンおよびその治療的使用 |
EP3473099A1 (en) | 2011-09-14 | 2019-04-24 | Samumed, LLC | Indazole-3-carboxamides and their use as wnt/b-catenin signaling pathway inhibitors |
PH12017500997A1 (en) | 2012-04-04 | 2018-02-19 | Samumed Llc | Indazole inhibitors of the wnt signal pathway and therapeutic uses thereof |
AU2013256141B2 (en) | 2012-05-04 | 2016-05-12 | Samumed, Llc | 1H-pyrazolo[3,4-b]pyridines and therapeutic uses thereof |
CA2897400A1 (en) | 2013-01-08 | 2014-07-17 | Samumed, Llc | 3-(benzoimidazol-2-yl)-indazole inhibitors of the wnt signaling pathway and therapeutic uses thereof |
WO2016040193A1 (en) | 2014-09-08 | 2016-03-17 | Samumed, Llc | 3-(1h-imidazo[4,5-c]pyridin-2-yl)-1h-pyrazolo[3,4-b]pyridine and therapeutic uses thereof |
WO2016040184A1 (en) | 2014-09-08 | 2016-03-17 | Samumed, Llc | 3-(3h-imidazo[4,5-b]pyridin-2-yl)-1h-pyrazolo[3,4-c]pyridine and therapeutic uses thereof |
WO2016040180A1 (en) | 2014-09-08 | 2016-03-17 | Samumed, Llc | 3-(1h-benzo[d]imidazol-2-yl)-1h-pyrazolo[3,4-c]pyridine and therapeutic uses thereof |
WO2016040188A1 (en) | 2014-09-08 | 2016-03-17 | Samumed, Llc | 3-(3h-imidazo[4,5-c]pyridin-2-yl)-1h-pyrazolo[3,4-c]pyridine and therapeutic uses thereof |
WO2016040182A1 (en) | 2014-09-08 | 2016-03-17 | Samumed, Llc | 2-(1h-indazol-3-yl)-1h-imidazo[4,5-c]pyridine and therapeutic uses thereof |
WO2016040185A1 (en) | 2014-09-08 | 2016-03-17 | Samumed, Llc | 2-(1h-indazol-3-yl)-3h-imidazo[4,5-b]pyridine and therapeutic uses thereof |
WO2016040190A1 (en) | 2014-09-08 | 2016-03-17 | Samumed, Llc | 3-(3h-imidazo[4,5-b]pyridin-2-yl)-1h-pyrazolo[3,4-b]pyridine and therapeutic uses thereof |
WO2016040181A1 (en) | 2014-09-08 | 2016-03-17 | Samumed, Llc | 3-(1h-imidazo[4,5-c]pyridin-2-yl)-1h-pyrazolo[3,4-c]pyridine and therapeutic uses thereof |
WO2017024021A1 (en) | 2015-08-03 | 2017-02-09 | Samumed, Llc | 3-(1h-pyrrolo[2,3-b]pyridin-2-yl)-1h-indazoles and therapeutic uses thereof |
WO2017023996A1 (en) | 2015-08-03 | 2017-02-09 | Samumed, Llc. | 3-(1h-pyrrolo[2,3-b]pyridin-2-yl)-1h-pyrazolo[3,4-b]pyridines and therapeutic uses thereof |
US10329309B2 (en) | 2015-08-03 | 2019-06-25 | Samumed, Llc | 3-(3H-imidazo[4,5-B]pyridin-2-yl)-1H-pyrazolo[4,3-B]pyridines and therapeutic uses thereof |
WO2017024025A1 (en) | 2015-08-03 | 2017-02-09 | Sunil Kumar Kc | 3-(1h-pyrrolo[2,3-c]pyridin-2-yl)-1h-pyrazolo[4,3-b]pyridines and therapeutic uses thereof |
WO2017023984A1 (en) | 2015-08-03 | 2017-02-09 | Samumed, Llc. | 3-(1h-pyrrolo[3,2-c]pyridin-2-yl)-1h-pyrazolo[3,4-c]pyridines and therapeutic uses thereof |
US10188634B2 (en) | 2015-08-03 | 2019-01-29 | Samumed, Llc | 3-(3H-imidazo[4,5-C]pyridin-2-yl)-1 H-pyrazolo[4,3-B]pyridines and therapeutic uses thereof |
WO2017023989A1 (en) | 2015-08-03 | 2017-02-09 | Samumed, Llc. | 3-(1h-benzo[d]imidazol-2-yl)-1h-pyrazolo[4,3-b]pyridines and therapeutic uses thereof |
US10195185B2 (en) | 2015-08-03 | 2019-02-05 | Samumed, Llc | 3-(1H-imidazo[4,5-C]pyridin-2-yl)-1H-pyrazolo[4,3-B]pyridines and therapeutic uses thereof |
WO2017023986A1 (en) | 2015-08-03 | 2017-02-09 | Samumed, Llc | 3-(1h-indol-2-yl)-1h-indazoles and therapeutic uses thereof |
WO2017023975A1 (en) | 2015-08-03 | 2017-02-09 | Samumed, Llc. | 3-(1h-pyrrolo[2,3-c]pyridin-2-yl)-1h-pyrazolo[3,4-c]pyridines and therapeutic uses thereof |
US10226448B2 (en) | 2015-08-03 | 2019-03-12 | Samumed, Llc | 3-(1H-pyrrolo[3,2-C]pyridin-2-yl)-1H-pyrazolo[3,4-B]pyridines and therapeutic uses thereof |
US10206909B2 (en) | 2015-08-03 | 2019-02-19 | Samumed, Llc | 3-(1H-pyrrolo[2,3-B]pyridin-2-yl)-1H-pyrazolo[4,3-B]pyridines and therapeutic uses thereof |
WO2017024010A1 (en) | 2015-08-03 | 2017-02-09 | Samumed, Llc. | 3-(1h-pyrrolo[3,2-c]pyridin-2-yl)-1h-indazoles and therapeutic uses thereof |
US10231956B2 (en) | 2015-08-03 | 2019-03-19 | Samumed, Llc | 3-(1H-pyrrolo[3,2-C]pyridin-2-YL)-1 H-pyrazolo[4,3-B]pyridines and therapeutic uses thereof |
US10285982B2 (en) | 2015-08-03 | 2019-05-14 | Samumed, Llc | 3-(1H-pyrrolo[2,3-B]pyridin-2-yl)-1H-pyrazolo[3,4-C]pyridines and therapeutic uses thereof |
WO2017023993A1 (en) | 2015-08-03 | 2017-02-09 | Samumed, Llc. | 3-(1h-indol-2-yl)-1h-pyrazolo[4,3-b]pyridines and therapeutic uses thereof |
US10166218B2 (en) | 2015-08-03 | 2019-01-01 | Samumed, Llc | 3-(1H-indol-2-yl)-1H-pyrazolo[3,4-C]pyridines and therapeutic uses thereof |
CA3004506A1 (en) | 2015-11-06 | 2017-05-11 | Samumed, Llc | Use of n-(5-(3-(7-(3- fluorophenyl)-3h-imidazo[4,5-c]pyridin-2-yl)-1h-indazol-5-yl)pyridin-3-yl)-3-methylbutanamide in the treatment of osteoarthritis |
CA3026076A1 (en) | 2016-06-01 | 2017-12-07 | Samumed, Llc | Process for preparing n-(5-(3-(7-(3-fluorophenyl)-3h-imidazo[4,5-c]pyridin-2-yl)-1h-indazol-5-yl)pyridin-3-yl)-3-methylbutanamide |
WO2018075858A1 (en) | 2016-10-21 | 2018-04-26 | Samumed, Llc | Methods of using indazole-3-carboxamides and their use as wnt/b-catenin signaling pathway inhibitors |
JP2019533702A (ja) | 2016-11-07 | 2019-11-21 | サミュメッド リミテッド ライアビリティ カンパニー | 単回用量の調整済み注射用製剤 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
YU54202A (sh) * | 2000-01-18 | 2006-01-16 | Agouron Pharmaceuticals Inc. | Jedinjenja indazola, farmaceutske smeše i postupci za stimulisanje i inhibiranje ćelijske proliferacije |
US7008953B2 (en) * | 2003-07-30 | 2006-03-07 | Agouron Pharmaceuticals, Inc. | 3, 5 Disubstituted indazole compounds, pharmaceutical compositions, and methods for mediating or inhibiting cell proliferation |
-
2005
- 2005-11-07 WO PCT/IB2005/003416 patent/WO2006054143A1/en active Application Filing
- 2005-11-15 AR ARP050104791A patent/AR052132A1/es unknown
- 2005-11-16 US US11/281,295 patent/US20060167056A1/en not_active Abandoned
- 2005-11-17 TW TW094140427A patent/TW200630360A/zh unknown
Also Published As
Publication number | Publication date |
---|---|
US20060167056A1 (en) | 2006-07-27 |
TW200630360A (en) | 2006-09-01 |
WO2006054143A8 (en) | 2006-07-27 |
WO2006054143A1 (en) | 2006-05-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR052132A1 (es) | Polimorfos de {5-[3-(4,6-difloruro-1h- benzoimidazol-2-il)-1h-indazol-5-il]-4- metil-piridin-3- ilmetil}-etil- amina | |
NO20171775A1 (no) | Ftalazinonderivat | |
AR112532A2 (es) | Compuestos de tetraciclina sustituidos con flúor en c7 | |
RS53292B (en) | CRYSTAL FORMS 2-THIAZOLYL-4-HINOLINYL-OXY DERIVATIVES, POWERFUL HCV INHIBITOR | |
RS52526B (en) | OXADIAZOL DERIVATIVES AND THEIR USE AS A POTENTIAL OF METABOTROPIC GLUTAMATE RECEPTORS-842 | |
AR108259A2 (es) | Compuestos para el control de nematodos de plantas | |
CR20140316A (es) | Derivados de indol como antagonistas receptores de s1p1 (divisional 10922) | |
CR8475A (es) | Fenilalanina-amidas sustituidas por benzoilo | |
UA94833C2 (en) | Substituted bicyclolactams | |
AP2412A (en) | Phosphonate analogs of HIV inhibitor compounds. | |
NO20080784L (no) | Histondeacetylaseinhibitorer | |
CY1112722T1 (el) | Μυκητοκτονες συνθεσεις | |
RS54386B1 (en) | ANTIVIRAL UNITS | |
WO2005074603A3 (en) | Aminobenzoxazoles as therapeutic agents | |
DK1838677T3 (da) | Krystallinske former af (R)-8-chlor-1.methyl-2,3,4,5-tetrahydro-1H-3-benzazepinhydrochlorid | |
CY1109911T1 (el) | Πυρρολοβενζοδιαζεπινες | |
RS52519B (en) | SPIROCYCLIC COMPOUNDS WHICH ARE INHIBITORS OF 11-ß HYDROXYL STEROID DEHYDROGENASE TYPE 1 | |
PE20060937A1 (es) | Derivados de sulfonilbencimidazol como agonistas del receptor cannabinoide 2 (cb2) | |
NO20075734L (no) | Tiofenforbindelser og trombopoietin reseptoractivatorer | |
RS52117B (en) | DIASTEREO-SELECTIVATE SYNTHESIS OF EGZO ANALOGUE IN HIMBAC | |
RS52739B (en) | UNITS USED FOR CHK1 INHIBITION | |
PA8663901A1 (es) | Derivados del (1,5-difenil-1h-pirazol-3-il)oxadiazol, su prepararacion y su aplicacion en terapéutica | |
RS52255B (en) | NALMEFEN HYDROCHLORIDE DIHYDRATE | |
RS52594B (en) | NON-STEROID ANTAGONISTS OF MINERALOCORTICOID RECEPTORS OBTAINED FROM 6H-DIBENZO [B, E] OXPINE | |
NO20083584L (no) | Bensoyl-piperidin derivater som 5HT2/D3 modulatorer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |